Results 221 to 230 of about 37,609 (272)
Discovery and Targeted Proteomic Studies Reveal Striatal Markers Validated for Huntington's Disease. [PDF]
Chelsky D +8 more
europepmc +1 more source
In this study, human astrocytes were obtained from induced pluripotent stem cells (iPSCs) of Parkinson's disease (PD) patients carrying the G2019S LRRK2 mutation, the most common genetic cause of PD. These astrocytes display a reactive and inflammatory profile, with increased GFAP levels, elevated cytokine release, and reduced support for dopaminergic ...
Veronica Mutti +13 more
wiley +1 more source
Huntington's Disease-Like 2 in a European Caucasian Patient. [PDF]
Rodrigues CC +5 more
europepmc +1 more source
From Synapses to Circuits, the Role of KIBRA and the WWC Family in Adaptive Brain Function
KIBRA (WWC1) has been the subject of scientific interest since its initial association with nonpathological variation in human memory performance. This review discusses subsequent work in animal models demonstrating that KIBRA supports memory function.
Lenora J. Volk
wiley +1 more source
Brain organoid models of Huntington's disease shift the focus towards neurodevelopment. [PDF]
Xu W, Prigione A.
europepmc +1 more source
This 15‐year bibliometric study (2009–2024) characterizes the global landscape of liquid–liquid phase separation (LLPS) in neurodegenerative diseases. We delineate the field's evolution from fundamental biophysics to clinical translation, emphasizing the liquid‐to‐solid transition of proteins like TDP‐43, tau, and α‐synuclein.
Chanyuan Zhang +6 more
wiley +1 more source
Temporal Muscle Thickness Correlates with Functional Decline in Huntington's Disease. [PDF]
Hemicker G +12 more
europepmc +1 more source
Screening a lysine‐targeting covalent fragment library against challenging protein targets revealed suitable warheads and characterized binding sites for the development of targeted covalent ligands. Covalent fragment screening has become an established strategy for identifying targetable amino acid residues or viable chemical starting points against ...
Noémi Csorba +18 more
wiley +1 more source
Effect of tetrabenazine on Stroop interference in Huntington's disease: Protocol. [PDF]
Fekete R.
europepmc +1 more source

